APA (7th ed.) Citation

KP, M., J, C., D, M., A, G., A, R., J, N., . . . TJ, M. (2021). Preclinical Evaluation of 89Zr-Df-IAB22M2C PET as an Imaging Biomarker for the Development of the GUCY2C-CD3 Bispecific PF-07062119 as a T Cell Engaging Therapy. Molecular imaging and biology, 23(6), 941. https://doi.org/10.1007/s11307-021-01621-0

Chicago Style (17th ed.) Citation

KP, Maresca, et al. "Preclinical Evaluation of 89Zr-Df-IAB22M2C PET as an Imaging Biomarker for the Development of the GUCY2C-CD3 Bispecific PF-07062119 as a T Cell Engaging Therapy." Molecular Imaging and Biology 23, no. 6 (2021): 941. https://doi.org/10.1007/s11307-021-01621-0.

MLA (9th ed.) Citation

KP, Maresca, et al. "Preclinical Evaluation of 89Zr-Df-IAB22M2C PET as an Imaging Biomarker for the Development of the GUCY2C-CD3 Bispecific PF-07062119 as a T Cell Engaging Therapy." Molecular Imaging and Biology, vol. 23, no. 6, 2021, p. 941, https://doi.org/10.1007/s11307-021-01621-0.